+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Transcatheter Mitral Valve"

From
From
China TAVR & TMV Market: Insights & Forecast (2024-2028) - Product Thumbnail Image

China TAVR & TMV Market: Insights & Forecast (2024-2028)

  • Report
  • June 2024
  • 51 Pages
  • China
From
From
Transcatheter Treatment: Procedures and Heart Valve Market - Product Thumbnail Image

Transcatheter Treatment: Procedures and Heart Valve Market

  • Report
  • February 2021
  • 144 Pages
  • Global
From
From
UAE Interventional Cardiology Devices Market, By Region, Competition, Forecast and Opportunities 2019-2029F - Product Thumbnail Image

UAE Interventional Cardiology Devices Market, By Region, Competition, Forecast and Opportunities 2019-2029F

  • Report
  • September 2024
  • 87 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
Heart Valve Devices Market Report and Forecast 2024-2032 - Product Thumbnail Image

Heart Valve Devices Market Report and Forecast 2024-2032

  • Report
  • October 2023
  • 140 Pages
  • Global
From
Loading Indicator

The Transcatheter Mitral Valve (TMV) is a type of cardiovascular device used to treat mitral valve regurgitation, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. TMV is a minimally invasive procedure that involves the insertion of a prosthetic valve into the heart through a catheter. This procedure is an alternative to open-heart surgery, which is more invasive and carries a higher risk of complications. TMV is a rapidly growing market, with a number of companies developing and marketing products. These companies are focused on improving the safety and efficacy of TMV procedures, as well as expanding the range of patients who can benefit from the procedure. Companies in the TMV market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and Neovasc. Show Less Read more